Inorganic solid acid antivirotic according to the present invention includes having in sour set of sites more than 0.005 gram. Inorganic solid acid preferably includes inorganic phosphate compounds, inorganic silicic acid compound or inorganic oxide. 3. are preferably no greater than in the acid centre of inorganic solid acid, acid strength (value)3.